Restoring life after organ failure.
eGenesis is a biotechnology company developing human-compatible organs using multiplexed gene editing and genome engineering. Focused on kidney, liver, and heart transplants via xenotransplantation from genetically modified pigs to end organ shortages and waitlists. Achieved FDA IND clearance for Phase 1/2/3 kidney trials.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountSep 2024
Mar 2021
Nov 2019
Mar 2017
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
